Efficacy of BIBF 1120 in patients with IPF is dose-dependent: Results from the TOMORROW trial
Ulrich Costabel, Luca Richeldi, Moises Selman, Dong Soon Kim, Kevin K. Brown, Kevin R. Flaherty, Paul W. Noble, Ganesh Raghu, Michèle Brun, Abhya Gupta, Matthias Klueglich, Nolwenn Juhel, Roland M. du Bois
European Respiratory Journal 2011 38: 172; DOI:
Ulrich Costabel
1Ruhrlandklinik and Medical Faculty, University of Duisburg-Essen, Essen, Germany
Luca Richeldi
2Center for Rare Lung Disease, University of Modena and Reggio Emilia, Modena, Italy
Moises Selman
3Instituto Nacional de Enfermedades Respiratorias, “Ismael Cosio Villegas”, México, Mexico
Dong Soon Kim
4Division of Pulmonary and Critical Care Medicine, Asan Medical Center, Seoul, Korea
Kevin K. Brown
5Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, National Jewish Health, Denver, United States
Kevin R. Flaherty
6Department of Internal Medicine, Pulmonary and Critical Care Division, University of Michigan, Ann Arbor, United States
Paul W. Noble
7Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, United States
Ganesh Raghu
8Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, United States
Michèle Brun
9Boehringer Ingelheim France S.A.S., Boehringer Ingelheim, Reims, France
Abhya Gupta
10Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim, Biberach, Germany
Matthias Klueglich
10Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim, Biberach, Germany
Nolwenn Juhel
9Boehringer Ingelheim France S.A.S., Boehringer Ingelheim, Reims, France
Roland M. du Bois
11National Heart & Lung Institute, Imperial College, London, United Kingdom
Vol 38 Issue Suppl 55
Table of Contents
Efficacy of BIBF 1120 in patients with IPF is dose-dependent: Results from the TOMORROW trial
Ulrich Costabel, Luca Richeldi, Moises Selman, Dong Soon Kim, Kevin K. Brown, Kevin R. Flaherty, Paul W. Noble, Ganesh Raghu, Michèle Brun, Abhya Gupta, Matthias Klueglich, Nolwenn Juhel, Roland M. du Bois
European Respiratory Journal Sep 2011, 38 (Suppl 55) 172;
Efficacy of BIBF 1120 in patients with IPF is dose-dependent: Results from the TOMORROW trial
Ulrich Costabel, Luca Richeldi, Moises Selman, Dong Soon Kim, Kevin K. Brown, Kevin R. Flaherty, Paul W. Noble, Ganesh Raghu, Michèle Brun, Abhya Gupta, Matthias Klueglich, Nolwenn Juhel, Roland M. du Bois
European Respiratory Journal Sep 2011, 38 (Suppl 55) 172;